Marimed Correlations
| MRMD Stock | USD 0.12 0.01 9.09% |
The current 90-days correlation between Marimed and AYR Strategies Class is 0.42 (i.e., Very weak diversification). The correlation of Marimed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Marimed Correlation With Market
Modest diversification
The correlation between Marimed and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Marimed and DJI in the same portfolio, assuming nothing else is changed.
Marimed |
The ability to find closely correlated positions to Marimed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Marimed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Marimed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Marimed to buy it.
Moving together with Marimed OTC Stock
| 0.78 | MKKGY | Merck KGaA ADR | PairCorr |
| 0.72 | MKGAF | MERCK Kommanditgesells | PairCorr |
| 0.78 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.73 | GLUC | Glucose Health | PairCorr |
| 0.65 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.87 | JNJ | Johnson Johnson Earnings Call This Week | PairCorr |
| 0.62 | VZ | Verizon Communications Earnings Call Tomorrow | PairCorr |
| 0.86 | XOM | Exxon Mobil Corp Aggressive Push | PairCorr |
| 0.79 | HPQ | HP Inc | PairCorr |
Moving against Marimed OTC Stock
| 0.78 | WMT | Walmart | PairCorr |
| 0.72 | TEVA | Teva Pharma Industries | PairCorr |
| 0.54 | TEVA | Teva Pharmaceutical | PairCorr |
| 0.47 | SIGL | Signal Advance | PairCorr |
| 0.43 | BAC | Bank of America Sell-off Trend | PairCorr |
| 0.35 | SLF | Sun Life Financial | PairCorr |
| 0.82 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.76 | AXP | American Express Earnings Call This Week | PairCorr |
| 0.74 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.59 | DIS | Walt Disney | PairCorr |
| 0.59 | JPM | JPMorgan Chase | PairCorr |
| 0.4 | MSFT | Microsoft Aggressive Push | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Marimed OTC Stock performing well and Marimed OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Marimed's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| VRNOF | 4.51 | (1.28) | 0.00 | 1.97 | 0.00 | 8.04 | 38.88 | |||
| CRLBF | 3.88 | (0.74) | 0.00 | 4.04 | 0.00 | 9.64 | 33.32 | |||
| AYRWF | 6.48 | (1.29) | 0.00 | 1.62 | 0.00 | 16.84 | 73.17 | |||
| GTBIF | 2.80 | (0.43) | 0.00 | (1.96) | 0.00 | 3.79 | 24.42 | |||
| CCHWF | 4.16 | 0.09 | 0.01 | 0.13 | 5.68 | 10.53 | 39.88 | |||
| TCNNF | 4.63 | (1.02) | 0.00 | 1.36 | 0.00 | 7.92 | 45.63 | |||
| GDNSF | 5.64 | 0.79 | 0.11 | 1.29 | 5.61 | 8.82 | 108.47 | |||
| GRUSF | 2.49 | (0.20) | 0.00 | (0.38) | 0.00 | 5.08 | 18.46 | |||
| SLGWF | 14.44 | 3.24 | 0.10 | (17.10) | 15.19 | 26.00 | 216.17 | |||
| BMMJ | 9.22 | 0.67 | 0.01 | (0.16) | 14.67 | 55.04 | 120.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Marimed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Marimed Corporate Management
Elected by the shareholders, the Marimed's board of directors comprises two types of representatives: Marimed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Marimed. The board's role is to monitor Marimed's management team and ensure that shareholders' interests are well served. Marimed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Marimed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Timothy Shaw | Chief Officer | Profile | |
| Steve West | VP Relations | Profile | |
| Howard Schacter | Chief Officer | Profile | |
| Sara Gullickson | VP Marketing | Profile | |
| Susan CPA | Chief Officer | Profile | |
| Jon Levine | President, CoFounder | Profile | |
| Charles Finnie | Chief Officer | Profile |